Corcept医疗(CORT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CORT Corcept医疗

休市中 08-16 16:00:00 EDT

33.97

-0.97

-2.78%

盘后33.97

+0.000.00%

17:32 EDT

最高35.03	最低33.90	成交量50.28万
今开34.89	昨收34.94	日振幅3.23%
总市值35.50亿	流通市值29.00亿	总股本1.04亿
成交额1,718万	换手率0.59%	流通股本8,537万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CORT","market":"US","secType":"STK","nameCN":"Corcept医疗","latestPrice":33.97,"timestamp":1723838400000,"preClose":34.94,"halted":0,"volume":502838,"hourTrading":{"tag":"盘后","latestPrice":33.97,"preClose":33.97,"latestTime":"17:32 EDT","volume":29825,"amount":1020676.985,"timestamp":1723843928969},"delay":0,"floatShares":85366972,"shares":104492469,"eps":1.131198,"marketStatus":"休市中","marketStatusCode":7,"change":-0.97,"latestTime":"08-16 16:00:00 EDT","open":34.89,"high":35.03,"low":33.9,"amount":17183809.8187,"amplitude":0.032341,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.131198,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1081915200000,"adjPreClose":34.94,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":33.97,"preClose":33.97,"latestTime":"17:32 EDT","volume":29825,"amount":1020676.985,"timestamp":1723843928969},"volumeRatio":0.8104773162085716,"impliedVol":0.1792,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/CORT/wiki","defaultTab":"wiki","newsList":[{"id":"1138361581","title":"异动解读 | Corcept Therapeutics盘前大跌7.82%,分析师上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1138361581","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138361581?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:13","pubTimestamp":1722867237,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics(CORT)今日盘前大跌7.82%,引发了市场的广泛关注。根据相关新闻报道,导致CORT股价大跌的主要原因是分析师上调了该公司的目标价。\n\nCanaccord Genuity分析师将CORT的目标价从38美元上调至78美元,这表明分析师对该公司的长期前景持乐观态度。分析师认为,CORT的产品线和管线前景看好,有望带来持续的收入增长。\n\n尽管如此,市场对于分析师上调目标价的反应出现了分歧。一些投资者认为目标价上调反映了公司的实际价值,而另一些投资者则担心目标价过高,存在一定的泡沫风险。因此,在利好消息的推动下,CORT股价短期内出现了大幅波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2457729358","title":"美国研究综述-Arista Networks、Penumbra、S&P Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729358","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457729358?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:03","pubTimestamp":1722859399,"startTime":"0","endTime":"0","summary":"    路透8月5日 - 华尔街证券分析师周三修改了对几家美国上市公司的评级和目标价，其中包括 Arista Networks、Penumbra 和 S&P Global。要闻  * 美国塔塔公司  ：摩根大通将目标价从230美元上调至240美元  * Arista Networks Inc   ：摩根大通将目标价从335美元上调至340美元  * Illinois Tool Works Inc   ：摩根大通将目标价从267美元上调至270美元  * Penumbra Inc   ：杰富瑞将目标价从280美元下调至215美元  * S&P Global Inc   ：摩根大通将目标价从550美元上调至565美元  以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXP","GL","ABBV","AWI","CZR","DH","IE0009355771.USD","MSFT","LU0496365809.HKD","CDP","NVDA","CCCS","BKNG","LU0048573561.USD","FLS","AMT","DAWN","LU1712237335.SGD","BY","LU1623119135.USD","PLOW","CNX","BV","AUB","CNOB","AGCO","BMRC","FSFG","CSR","IE00BKVL7J92.USD","ADM","AMD","EQR","ECL","AX","CNO","BYON","LU0426412945.USD","AEP","ALB","BGC","CNC","CORT","EA","CVLT","FRSH","LU","LU0557290698.USD","GLW","ATRC"],"gpt_icon":1},{"id":"2456232260","title":"Corcept医疗2024财年第二财季实现净利润35.12百万美元，同比增加28.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456232260","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456232260?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:19","pubTimestamp":1722615558,"startTime":"0","endTime":"0","summary":"8月3日，Corcept医疗公布财报，公告显示公司2024财年第二财季净利润为35.12百万美元，同比增加28.36%；其中营业收入为1.64亿美元，同比增加38.98%，每股基本收益为0.34美元。从资产负债表来看，Corcept医疗总负债1.18亿美元，其中短期债务44000.00美元，资产负债比为6.06，流动比率为5.56。机构评级：截至2024年8月3日，当前有5家机构对Corcept医疗目标价做出预测，其中目标均价为59.60美元，其中最低目标价为38.00美元，最高目标价为78.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408030019299f0954f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408030019299f0954f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT"],"gpt_icon":0},{"id":"2456287214","title":"Corcept医疗盘中异动 早盘大幅下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456287214","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456287214?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:47","pubTimestamp":1722606439,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时47分，Corcept医疗股票出现波动，股价快速下跌5.06%。截至发稿，该股报36.02美元/股，成交量7.7102万股，换手率0.07%，振幅1.92%。Corcept医疗股票所在的生物技术行业中，整体跌幅为0.86%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214720af95a6f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214720af95a6f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT","BK4532","BK4007"],"gpt_icon":0},{"id":"1189371012","title":"异动解读 | Corcept医疗股价大涨 分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1189371012","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189371012?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:54","pubTimestamp":1722437676,"startTime":"0","endTime":"0","summary":"Corcept医疗(CORT)股价今日盘中大涨5.12%,引发市场关注。分析师指出,公司最新获批的一款新药前景广阔,有望成为公司未来业绩增长的新动力。\n\n根据相关报道,Corcept医疗近期获得FDA批准上市一款新型糖尿病药物。这款新药在临床试验中显示出良好的疗效和安全性,有望在糖尿病治疗领域占据一席之地。分析师预计,新药上市后将为公司带来可观的收益,推动公司业绩持续增长。\n\n此外,分析师普遍看好Corcept医疗的长期发展前景。公司在内分泌和代谢疾病领域拥有丰富的研发管线,未来仍有多款潜力新药有望问世。随着新药上市和销售网络的不断扩张,公司有望在未来几年内保持良好的增长态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2455137957","title":"Corcept医疗盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455137957","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455137957?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:00","pubTimestamp":1722434448,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日22时00分，Corcept医疗股票出现异动，股价大幅拉升5.00%。截至发稿，该股报37.93美元/股，成交量10.6604万股，换手率0.10%，振幅5.26%。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.60%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731220049968224af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731220049968224af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT","BK4532","BK4007"],"gpt_icon":0},{"id":"2455918188","title":"美国研究综述-Arista Networks、Penumbra、S&P Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2455918188","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455918188?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:24","pubTimestamp":1722425076,"startTime":"0","endTime":"0","summary":"    路透7月31日 - 华尔街证券分析师周三修改了对几家美国上市公司的评级和目标价，其中包括 Arista Networks、Penumbra 和 S&P Global。要闻  * 美国塔塔公司  ：摩根大通将目标价从230美元上调至240美元  * Arista Networks Inc   ：摩根大通将目标价从335美元上调至340美元  * Illinois Tool Works Inc   ：摩根大通将目标价从267美元上调至270美元  * Penumbra Inc   ：杰富瑞将目标价从280美元下调至215美元  * S&P Global Inc   ：摩根大通将目标价从550美元上调至565美元  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU","BKNG","ANET","BY","BYON","CORT","AX","BTI","ATRC","FLS","LU0310800965.SGD","CNX","MRK","MSFT","PYPL","AEP","ABBV","PFE","CCCS","BK4148","ADM","CSR","GL","IE00BFXG1179.USD","FSFG","CNC","ALB","LU0496365809.HKD","CVLT","NVDA","AUB","AMT","CDP","PLOW","AGCO","AMD","CNOB","ECL","DH","EQR","EA","BV","BMRC","LU1670628061.USD","GLW","BGC","CNO","LU0820561909.HKD","AWI","FRSH","BK4020","DAWN","CZR","BK4551","EXP"],"gpt_icon":1},{"id":"2455890761","title":"美国研究综述-Arista Networks、Penumbra、S&P Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2455890761","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455890761?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:24","pubTimestamp":1722425076,"startTime":"0","endTime":"0","summary":"    路透7月31日 - 华尔街证券分析师周三修改了对几家美国上市公司的评级和目标价，其中包括 Arista Networks、Penumbra 和 S&P Global。要闻  * 美国塔塔公司  ：摩根大通将目标价从230美元上调至240美元  * Arista Networks Inc   ：摩根大通将目标价从335美元上调至340美元  * Illinois Tool Works Inc   ：摩根大通将目标价从267美元上调至270美元  * Penumbra Inc   ：杰富瑞将目标价从280美元下调至215美元  * S&P Global Inc   ：摩根大通将目标价从550美元上调至565美元  以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU","BKNG","ANET","BY","BYON","CORT","AX","BTI","ATRC","FLS","LU0310800965.SGD","CNX","MSFT","AEP","ABBV","CCCS","BK4148","ADM","CSR","GL","IE00BFXG1179.USD","FSFG","CNC","ALB","LU0496365809.HKD","CVLT","NVDA","AUB","AMT","CDP","PLOW","AGCO","CNOB","ECL","DH","EQR","EA","BV","BMRC","LU1670628061.USD","GLW","BGC","CNO","LU0820561909.HKD","AWI","FRSH","BK4020","DAWN","CZR","BK4551","EXP"],"gpt_icon":1},{"id":"2455954319","title":"加拿大投资银行集团：维持Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由38.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455954319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455954319?lang=zh_cn&edition=full","pubTime":"2024-07-30 23:28","pubTimestamp":1722353291,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4532","BK4007","LENZ","CORT"],"gpt_icon":0},{"id":"1126660248","title":"异动解读 | Corcept Therapeutics股价大涨5.34%,分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1126660248","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126660248?lang=zh_cn&edition=full","pubTime":"2024-07-30 20:02","pubTimestamp":1722340961,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics公司今日盘前股价大涨5.34%,引发市场广泛关注。分析师普遍认为,这主要源于公司前景向好的预期。分析师表示,公司旗舰产品Korlym在治疗库欣综合征方面具有独特优势,预计未来几年销售将持续增长。同时,公司正在开发新的治疗性药物管线,有望进一步扩大收入来源。另一家券商Jefferies此前也曾上调Corcept Therapeutics的目标股价,并给予\"买入\"评级。分析师认为,公司在现金流和盈利能力方面表现出色,有利于支持未来研发投入和业务拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2455598700","title":"Piper Sandler：维持Corcept Therapeutics(CORT.US)评级，由增持调整至增持评级, 目标价由35.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455598700","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455598700?lang=zh_cn&edition=full","pubTime":"2024-07-30 19:19","pubTimestamp":1722338351,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CORT","BK4139","BK4532","LENZ","BK4007"],"gpt_icon":0},{"id":"2455812439","title":"HC Wainwright &amp; Co.：维持Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由40.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455812439","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455812439?lang=zh_cn&edition=full","pubTime":"2024-07-30 18:39","pubTimestamp":1722335988,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","CORT","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2455607319","title":"美国研究综述-Hubspot、麦当劳、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2455607319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455607319?lang=zh_cn&edition=full","pubTime":"2024-07-30 16:53","pubTimestamp":1722329620,"startTime":"0","endTime":"0","summary":"    路透7月30日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Hubspot、麦当劳和特斯拉。要闻  * Ameriprise Financial Inc   ：KBW将其目标价从470美元下调至460美元 * First Citizens Bancshares   ：杰富瑞将目标价从2005美元上调至2460美元 * Hubspot Inc   ：TD Cowen将目标价从680美元下调至600美元 * 麦当劳   ：Piper Sandler将目标价从291美元下调至279美元 * 特斯拉  ：大和资本市场将目标价从 180 美元上调至 225 美元 以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOC","FISI","FBIN","FFIV","MCD","IE00B19Z9Z06.USD","AMP","CFR","HOLX","BK4595","LU2360032135.SGD","LU0965509101.SGD","EGP","BMBL","CSR","ULCC","HUBS","CL","DLTR","CORT","BRX","AMG","GH","CUZ","AMTB","COLB","BSY","BWFG","TSLA","LU2433249047.HKD","BK4504","CVRX","DG","FCNCA","FIVE","AAP","FR","FRBA","CTRI","CFLT","AVPT","FFIC","AZO","ARES","CIVB","HTBK","TSLL","LU0417517546.SGD"],"gpt_icon":1},{"id":"2455073166","title":"美国研究综述-Hubspot、麦当劳、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2455073166","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455073166?lang=zh_cn&edition=full","pubTime":"2024-07-30 16:53","pubTimestamp":1722329620,"startTime":"0","endTime":"0","summary":"    路透7月30日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Hubspot、麦当劳和特斯拉。要闻  * Ameriprise Financial Inc   ：KBW将其目标价从470美元下调至460美元 * First Citizens Bancshares   ：杰富瑞将目标价从2005美元上调至2460美元 * Hubspot Inc   ：TD Cowen将目标价从680美元下调至600美元 * 麦当劳   ：Piper Sandler将目标价从291美元下调至279美元 * 特斯拉  ：大和资本市场将目标价从 180 美元上调至 225 美元 以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRBA","CORT","ARES","AMP","AZO","FR","LU2360032135.SGD","FFIC","FFIV","DOC","DG","TSLL","CL","HTBK","FIVE","LU2433249047.HKD","LU0965509101.SGD","FISI","BRX","GH","AMG","DLTR","CTRI","BK4504","TSLA","MCD","AMTB","COLB","CVRX","FBIN","BMBL","BSY","AVPT","CIVB","AAP","CFR","IE00B19Z9Z06.USD","HOLX","CSR","BWFG","LU0417517546.SGD","ULCC","CUZ","FCNCA","BK4595","EGP","HUBS","CFLT"],"gpt_icon":1},{"id":"2454593305","title":"Corcept Therapeutics Inc   预计每股收益23美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2454593305","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454593305?lang=zh_cn&edition=full","pubTime":"2024-07-27 05:24","pubTimestamp":1722029050,"startTime":"0","endTime":"0","summary":"   * Corcept Therapeutics Inc    将于7月29日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州门洛帕克的公司的营收将从去年同期的1.1772亿美元增至1.55226亿美元，增幅为31.9%。* LSEG 分析师对 Corcept Therapeutics Inc 的平均预期为每股收益 23 美分。* 华尔街对 Corcept Therapeutics Inc 的 12 个月目标价中位数为 40.00 美元，高于其 34.87 美元的最新收盘价。7月26日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","LENZ"],"gpt_icon":0},{"id":"2444199667","title":"Truist Securities：维持Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由65.","url":"https://stock-news.laohu8.com/highlight/detail?id=2444199667","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444199667?lang=zh_cn&edition=full","pubTime":"2024-06-17 23:27","pubTimestamp":1718638038,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","CORT","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2443133673","title":"Corcept医疗盘中异动 早盘急速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443133673","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443133673?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:43","pubTimestamp":1718372634,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时43分，Corcept医疗股票出现波动，股价急速下跌5.11%。截至发稿，该股报29.90美元/股，成交量9.8203万股，换手率0.09%，振幅3.71%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.11%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614214354968144f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614214354968144f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CORT","BK4532"],"gpt_icon":0},{"id":"2441253058","title":"Corcept医疗盘中异动 下午盘股价大涨5.02%报32.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441253058","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441253058?lang=zh_cn&edition=full","pubTime":"2024-06-05 01:14","pubTimestamp":1717521289,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日01时14分，Corcept医疗股票出现异动，股价快速上涨5.02%。截至发稿，该股报32.87美元/股，成交量41.6569万股，换手率0.40%，振幅4.60%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.97%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605011449aef35930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605011449aef35930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","CORT","BK4007"],"gpt_icon":0},{"id":"2440944233","title":"Truist Securities：重申Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由44.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440944233","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440944233?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:21","pubTimestamp":1717507308,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4532","BK4007","LENZ","CORT"],"gpt_icon":0},{"id":"2438737223","title":"BUZZ-荷尔蒙紊乱药物在后期研究中获得成功，Corcept 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2438737223","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438737223?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:40","pubTimestamp":1716903647,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月28日 - ** Corcept Therapeutics   股价大涨10.3%至30.34美元 ** 公司称其实验性药物有助于库欣综合征患者维持血压控制，这是其后期研究的主要目标 ** 库欣综合征是一种疾病，当人体长期制造过多的皮质醇激素时就会发生这种疾病。** 药物 relacorilant 对高血压、高血糖和这些患者的其他症状也有明显改善。 ** CORT 计划在第三季度提交申请，寻求美国监管部门的批准** 截至上一交易日收盘，CORT 股价累计下跌约 15","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","BK4532","BK4007","BUZZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corcept.com","stockEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.022},{"period":"3month","weight":0.2093},{"period":"6month","weight":0.4958},{"period":"1year","weight":0.1134},{"period":"ytd","weight":0.0459}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corcept Therapeutics Incorporated于1998年5月13日在特拉华州注册成立。该公司是一家商业阶段公司，从事发现和开发药物，通过调节激素皮质醇的作用来治疗严重的内分泌、肿瘤、代谢和神经系统疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.000884},{"month":2,"riseRate":0.45,"avgChangeRate":0.019494},{"month":3,"riseRate":0.75,"avgChangeRate":0.104079},{"month":4,"riseRate":0.55,"avgChangeRate":0.017063},{"month":5,"riseRate":0.47619,"avgChangeRate":0.003602},{"month":6,"riseRate":0.47619,"avgChangeRate":0.043515},{"month":7,"riseRate":0.47619,"avgChangeRate":-0.002799},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.010028},{"month":9,"riseRate":0.4,"avgChangeRate":0.043238},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003475},{"month":11,"riseRate":0.45,"avgChangeRate":0.007788},{"month":12,"riseRate":0.45,"avgChangeRate":0.064599}],"exchange":"NASDAQ","name":"Corcept医疗","nameEN":"Corcept Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corcept医疗(CORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corcept医疗(CORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corcept医疗,CORT,Corcept医疗股票,Corcept医疗股票老虎,Corcept医疗股票老虎国际,Corcept医疗行情,Corcept医疗股票行情,Corcept医疗股价,Corcept医疗股市,Corcept医疗股票价格,Corcept医疗股票交易,Corcept医疗股票购买,Corcept医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corcept医疗(CORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corcept医疗(CORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}